226 related articles for article (PubMed ID: 2654294)
1. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
Gillard BK; Thomas JW; Nell LJ; Marcus DM
J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
[TBL] [Abstract][Full Text] [Related]
2. Target antigens in autoimmune diabetes: pancreatic gangliosides.
Dionisi S; Dotta F; Diaz-Horta O; Carabba B; Viglietta V; Di Mario U
Ann Ist Super Sanita; 1997; 33(3):433-5. PubMed ID: 9542277
[TBL] [Abstract][Full Text] [Related]
3. Anti-ganglioside autoantibodies in type 1 diabetes.
Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
[TBL] [Abstract][Full Text] [Related]
4. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
5. GT3 and its O-acetylated derivative are the principal A2B5-reactive gangliosides in cultured O2A lineage cells and are down-regulated along with O-acetyl GD3 during differentiation to oligodendrocytes.
Farrer RG; Quarles RH
J Neurosci Res; 1999 Aug; 57(3):371-80. PubMed ID: 10412028
[TBL] [Abstract][Full Text] [Related]
6. A distinct ganglioside composition of rat pancreatic islets.
Saito M; Sugiyama K
Arch Biochem Biophys; 2000 Apr; 376(2):371-6. PubMed ID: 10775425
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens on rat islet tumors.
Thomas JW; Virta VJ; Nell LJ
J Immunol; 1987 May; 138(9):2896-901. PubMed ID: 3033078
[TBL] [Abstract][Full Text] [Related]
8. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
9. Determination of islet cell antibodies using an ELISA system with a preparation of rat insulinoma (RIN A2) cells.
Scherbaum WA; Seissler J; Hedderich U; Boehm BO; Specker M; Pfeiffer EF
Diabetes Res; 1989 Feb; 10(2):97-102. PubMed ID: 2663322
[TBL] [Abstract][Full Text] [Related]
10. Quantitative estimation of islet cell surface antibodies in sera of patients with diabetes mellitus, using BK virus-induced insulinoma, rat islet or fish islet cells and 125I-antihuman IgG antibody.
Negishi K; Kawazu S; Ishii J; Kanazawa Y
J Clin Lab Immunol; 1986 Apr; 19(4):155-9. PubMed ID: 3014151
[TBL] [Abstract][Full Text] [Related]
11. Determination of islet cell surface antibodies in first-degree relatives of type 1 diabetic patients using rat insulinoma cells.
Ziegler B; Heinke P; Schlosser M; Rjasanowski I; Michaelis D; Ziegler M
Diabetes Res; 1989 Sep; 12(1):25-9. PubMed ID: 2698302
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative.
Dubois C; Manuguerra JC; Hauttecoeur B; Maze J
J Biol Chem; 1990 Feb; 265(5):2797-803. PubMed ID: 2303428
[TBL] [Abstract][Full Text] [Related]
13. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
14. Screening monoclonal islet cell surface antibodies (ICSA) by radioimmunoassay--detection of crossreactivity with ICSA from insulin-dependent (type 1) diabetic patients.
Keilacker H; Ziegler B; Diaz-Alonso JM; Witt S; Woltanski KP; Kohnert KD; Ziegler M
Exp Clin Endocrinol; 1988 Mar; 91(1):13-9. PubMed ID: 3286271
[TBL] [Abstract][Full Text] [Related]
15. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
16. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
17. Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects.
Tiberti C; Dotta F; Anastasi E; Torresi P; Multari G; Vecci E; Andreani D; Di Mario U
Autoimmunity; 1995; 22(1):43-8. PubMed ID: 8882421
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
19. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
20. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
